Literature DB >> 7593463

In vitro synthesis of human IgE is suppressed by human IgG.

H Haas1, M Schlaak.   

Abstract

Recently it has been shown that intravenous immunoglobulin (IVIG) preparations suppress the in vitro synthesis of IgG, IgA, and IgM. In this paper we demonstrate that IVIG and IgG purified from a single donor's serum also suppress the in vitro synthesis of IgE. We had noticed this effect when we added human serum (HS) to in vitro cultures for IgE synthesis. The interleukin-4 (IL-4)-induced IgE synthesis from human peripheral blood mononuclear cells (PBMC) in the presence of fetal calf serum (FCS) was suppressed by HS in a dose-dependent fashion. The following results indicate that this suppression is mediated by IgG: (1) IVIG preparations, which consist mainly of IgG, suppressed the IgE synthesis from IL-4-stimulated PBMC in a dose-dependent way; (2) when HS was fractionated by protein G sepharose or anti-IgG sepharose, the eluate fractions (containing IgG), but not the effluent fractions (void of IgG) suppressed IgE synthesis, whereas the opposite was found when HS was fractionated by FCS-coupled sepharose. We conclude from these data that human IgG preparations suppress the in vitro synthesis not only of the IgG, IgA, and IgM isotypes, but also of the IgE isotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593463     DOI: 10.1007/BF01541086

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  16 in total

1.  Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin.

Authors:  M Toyoda; X Zhang; A Petrosian; O A Galera; S J Wang; S C Jordan
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

2.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

3.  Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones.

Authors:  H Yssel; J E De Vries; M Koken; W Van Blitterswijk; H Spits
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

Review 4.  Immunodeficiency diseases.

Authors:  R H Buckley
Journal:  JAMA       Date:  1987-11-27       Impact factor: 56.272

5.  Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gamma-globulin therapy in patients with idiopathic thrombocytopenic purpura.

Authors:  T Tsubakio; Y Kurata; S Katagiri; Y Kanakura; T Tamaki; J Kuyama; Y Kanayama; T Yonezawa; S Tarui
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

6.  Beneficial effect of human therapeutic intravenous immunoglobulins (IVIg) in mercuric-chloride-induced autoimmune disease of Brown-Norway rats.

Authors:  F Rossi; B Bellon; M C Vial; P Druet; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

7.  Human B cell differentiation. II. Suppression by T cells of T-dependent and T-independent plasma cell maturation.

Authors:  L T Bich-Thuy; J Brochier
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

8.  Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.

Authors:  F Rossi; Y Sultan; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

9.  Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effects on circulating T cell subsets and PWM-induced antibody synthesis in vitro.

Authors:  F Dammacco; G Iodice; N Campobasso
Journal:  Br J Haematol       Date:  1986-01       Impact factor: 6.998

10.  A cell culture system that enhances mononuclear cell IgE synthesis induced by recombinant human interleukin-4.

Authors:  J L Claassen; A D Levine; R H Buckley
Journal:  J Immunol Methods       Date:  1990-02-09       Impact factor: 2.303

View more
  2 in total

1.  The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipids.

Authors:  W M Vuist; I N Van Schaik; M Van Lint; A Brand
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

Review 2.  The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid.

Authors:  Kelly N Messingham; Tyler P Crowe; Janet A Fairley
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.